Gernot Langer

Title: Gernot Langer: Innovator in Pharmaceutical Chemistry

Introduction

Gernot Langer is a notable inventor based in Falkensee, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzimidazole derivatives. With a total of two patents to his name, Langer's inventions focus on the treatment of disorders associated with the EP4 receptor.

Latest Patents

Langer's latest patents include "Benzimidazole derivatives as EP4 ligands" and "Benzimidazole derivatives as EP4 antagonists." The first patent relates to novel benzimidazole derivatives of a specific general formula, detailing processes for their preparation and their application in pharmaceutical compositions aimed at treating disorders linked to the EP4 receptor. The second patent also focuses on benzimidazole derivatives, emphasizing their use in producing pharmaceutical compositions for diseases associated with the EP4 receptor.

Career Highlights

Throughout his career, Gernot Langer has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer Animal Health. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Langer has collaborated with notable colleagues such as Olaf Peters and Nico Bräuer. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Gernot Langer's work in the field of pharmaceutical chemistry, particularly with his patents on benzimidazole derivatives, showcases his commitment to innovation and improving medical treatments. His contributions are significant in the ongoing development of therapies targeting the EP4 receptor.